Updated Jul 24, 2026
/Scribe shares surge in public market debut with Eli Lilly and Sanofi as backers/Verizon lifts guidance as international governments respond to new tariff policies/Lisata Therapeutics terminates $4-a-share Kuva Labs merger after financing failure/Sidus Space Names Alan Khalili CFO, Effective July 27/Intel shares fall as 25% revenue jump marks fastest growth since 2011/GrafTech posts $40 million Q2 loss as electrode pricing slides/Scribe shares surge in public market debut with Eli Lilly and Sanofi as backers/Verizon lifts guidance as international governments respond to new tariff policies/Lisata Therapeutics terminates $4-a-share Kuva Labs merger after financing failure/Sidus Space Names Alan Khalili CFO, Effective July 27/Intel shares fall as 25% revenue jump marks fastest growth since 2011/GrafTech posts $40 million Q2 loss as electrode pricing slides
A darkened newsroom before dawn, monitors glowing and a single red LIVE light over the anchor desk
Markets desk · July 24, 2026

Scribe shares surge in public market debut with Eli Lilly and Sanofi as backers

NEW YORK, July 24. Shares of Scribe surged during the company's public market debut, the release shows. Scribe is backed by Eli Lilly (L

Latest from the wire

See all bulletins →

Top of the hour

Updated July 23, 2026

The Wire — newest first

Every bulletin dated and ordered by recency. Older stories fade down the board as fresher ones break.

See all bulletins
The alert, before the trend

Don't refresh the feed. Let the feed find you.

Subscribe and we'll send the bulletin the instant our desk confirms it — verified, timestamped, and straight to your inbox.

Subscribe by email